Taiko Pharmaceutical Co.,Ltd. (TYO:4574)
Japan · Delayed Price · Currency is JPY 284.00
-3.00 (-1.05%)
Aug 7, 2025, 2:37 PM JST
Acelyrin Market Cap
Taiko Pharmaceutical has a market cap or net worth of 14.41 billion as of August 6, 2025. Its market cap has decreased by -37.28% in one year.
Market Cap
14.41B
Enterprise Value
11.36B
Revenue
6.07B
Ranking
n/a
PE Ratio
20.06
Stock Price
$284.00
Market Cap Chart
Since March 18, 2009, Taiko Pharmaceutical's market cap has increased from 10.71B to 14.41B, an increase of 34.44%. That is a compound annual growth rate of 1.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 14.41B | -13.29% |
| Dec 30, 2024 | 16.61B | 10.16% |
| Dec 29, 2023 | 15.08B | -12.28% |
| Dec 30, 2022 | 17.19B | -52.12% |
| Dec 30, 2021 | 35.91B | -48.57% |
| Dec 30, 2020 | 69.83B | 50.51% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.02T |
| Daiichi Sankyo Company | 6,600.46B |
| Takeda Pharmaceutical Company | 6,590.05B |
| HOYA Corporation | 6,191.93B |
| Otsuka Holdings | 3,913.98B |
| Terumo | 3,753.27B |
| Astellas Pharma | 2,786.62B |
| Shionogi & | 2,166.95B |